Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor
Crossref DOI link: https://doi.org/10.1007/s00280-015-2725-8
Published Online: 2015-03-17
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Inkeun
Lee, Jae-Lyun
Ahn, Jin-Hee
Lee, Dae-Ho
Lee, Kyoo-Hyung
You, Dalsan
Jeong, In Gab
Song, Cheryn
Hong, Bumsik
Hong, Jun Hyuk
Ahn, Hanjong
Text and Data Mining valid from 2015-03-17